Search results
Review the results we have found for you.
Use the filters to narrow down the results list and easily find the trial you look for.
1 Study StatusRecruiting1 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
- Cancer,
- Head and Neck Cancer,
- Squamous Cell Carcinoma,
- Solid Tumors,
- Advanced Solid Tumors,
- Lung Cancer,
- Non-Small Cell Lung Cancer (NSCLC),
- Breast Cancer,
- Triple Negative Breast Cancer,
- Colorectal Cancer (CRC),
- Gastric Cancer,
- Non Small Cell Lung Carcinoma,
- Bladder Cancer,
- Urothelial Carcinoma,
- Squamous Cell Carcinoma of the Head and Neck (SCCHN),
- Esophageal Cancer,
- Hepatocellular Carcinoma (HCC),
- Metastatic Solid Tumors,
- Skin Cancer,
- Malignant Melanoma,
- Renal Cell Cancer (RCC),
- Clear Cell Renal Cell Carcinoma,
- Melanoma,
- Cervical Cancer
- NCT05581004, GO43860, 2021-006708-34
2 Study StatusActive, not recruiting2 A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma
- Cancer,
- Esophageal Cancer
- NCT04540211, YO42138
3 Study StatusActive, not recruiting3 A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) (Morpheus-Gastric Cancer)
- Cancer,
- Gastric and Gastroesophageal Junction Carcinoma,
- Gastroesophageal Junction Adenocarcinoma,
- Gastric Cancer,
- Gastric Adenocarcinoma,
- Esophageal Cancer,
- Esophageal Carcinoma
- NCT03281369, YO39609, 2016-004529-17